C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 39/395 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C12Q 1/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2309358
The present invention relates to compositions and methods of treating and diagnosing disorders characterized by the presence of antigens associated with inflammatory diseases and/or cancer, and nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, vectors and host cells expressing such antigens PRO301, PRO362 or PRO245.
L'invention concerne des compositions et des procédés de traitement et de diagnostic de troubles caractérisés par la présence d'antigènes associés à des maladies inflammatoires et/ou au cancer, et des séquences nucléotidiques, contenant des étiquettes de séquence exprimées, des sondes oligonucléotidiques, des polypeptides, des vecteurs et des cellules hôtes exprimant les antigènes PRO301, PRO362 ou PRO245.
Ashkenazi Avi
Fong Sherman
Goddard Audrey
Gurney Austin L.
Napier Mary A.
Dennison Associates
Genentech Inc.
LandOfFree
A-33 related antigens and their pharmacological uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A-33 related antigens and their pharmacological uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A-33 related antigens and their pharmacological uses will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1747349